New Study: Pine Bark Extract Reduces ADHD Symptoms In Children

New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. New Research Clarifies Nutritional Roles Of Calcium, Vitamin D, and Protein In Bone Health and Fracture Risk Research presented at the IOF World Congress on Osteoporosis in Toronto, Canada indicates that calcium in food might do more to protect bones than supplemental calcium in pill form, shows also that vitamin D supplements reduce fracture risk only in the presence of additional calcium; and that high protein foods also promote bone health. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Recent Study Confirms Sabinsa's Selenium SeLECT More Bioavailable Than Other Forms of Selenium recent study entitled "Effects of Chemical Form of Selenium on Plasma Biomarkers in a High-Dose Human Supplementation Trial" published in the April 2006 edition of Cancer Epidemiology, Biomarkers & Prevention, found that bioavailability of selenium was greatest for selenomethionine (as Selenium SeLECT from Sabinsa Corporation), less for high-selenium yeast and the least for sodium selenite. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. Encouraging Results for Folic Acid for Cancer Prevention Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. New Research Backs Role of Dietary Lignans Intake in Breast Health Study measuring enterolactone and genistein levels in 220 premenopausal women and 237 age-matched controls, reported in In the June 2006 issue of the European Journal of Cancer Prevention suggests that there is a decrease in pre-menopausal breast cancer risk in tandem with increased concentrations of plasma enterolactone and no such significant association noted with genistein. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Study Results Indicate Seditol® is Both Safe and Effective for Getting a Good Night’s Sleep Open label, single center study conducted at the Living Longer Clinic in Cincinnati, Ohio on more than six-hundred participants examined the safety and efficacy of Seditol® while measuring its effects on quality of sleep, with 92% of the subjects reporting Seditol® helped them relax; 88% reporting Seditol® helped them have a restful night’s sleep; and 89% reporting Seditol® helped reduce fatigue due to lack of sleep. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. Acupuncture relieves symptoms of fibromyalgia, Mayo Clinic study finds Mayo Clinic study involving 50 fibromyalgia patients enrolled in a randomized, controlled trial to determine if acupuncture improved their symptoms indicates that symptoms of those who received acupuncture significantly improved compared with the control group. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Research Shows Pycnogenol® Reduces Hyperactivity, Increases Concentration HOBOKEN, NJ - June 16, 2006 - A new study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, everyday for one month. In the randomized, double-blind placebo-controlled study, Pycnogenol helped reduce hyperactivity and improve attention, concentration and motor-visual coordination in children with ADHD. "These findings are especially notable for parents who are concerned about overmedicating children diagnosed with ADHD. Many families are seeking natural options to avoid the potentially dangerous side effects of prescription drugs," said Dr. Peter Rohdewald, Institute of Pharmaceutical Chemistry at Germany's University of Munster and one of the authors of the study. "The results of this study show Pycnogenol may serve as a safe, effective treatment for children diagnosed with ADHD. French maritime pine bark extract reduced hyperactivity among study participants, while improving attention and visual-motor coordination and concentration of these children," said Rohdewald. The study sampled 61 out-patients with ADHD with an average age of 9 ½ years, from the Department of Child Psychology at the Children University Hospital in Slovakia. Forty-one patients received Pycnogenol and 16 received placebo. Patients were not supplemented with any other drugs or with vitamins E or C during the study. The placebo contained lactose (58 mg) and cellulose (65 mg). Participants in the Pycnogenol group received 1 mg of Pycnogenol or placebo for every kilogram of body weight, on a daily basis each morning, for one month. Participants were given a basic psychiatric examination; an evaluation by teachers and parents using the Child Attention Problems scale (CAP), the Connor's Teacher Rating Scale (CTRS) and Connor's Parent Rating Scale (CPRS) and a psychological investigation before treatment, one month after the study began and one month after the end of the study. After one month of Pycnogenol treatment, the participants' teachers compared the pre-test CAP and CTRS results with those scores after one month of treatment with either Pycnogenol or placebo. There was a significant drop in hyperactivity and inattention compared to start of the study and placebo. The CPRS results, evaluated by parents after one month of treatment, showed a decrease in hyperactivity compared to the scores at the start of the study. The results for motor-visual coordination and concentration showed a significant increase for participants who took Pycnogenol after one month of the study period compared to before the study started. Participants who took placebo showed no significant improvement in these scores. The researchers also found that, one month after termination of treatment, symptoms returned to their levels as measured before the study started in the Pycnogenol group, strongly suggesting the antioxidant's effect on reducing ADHD symptoms. According to the U.S. Centers for Disease Control and Prevention (CDC), 7.8% of American Children are diagnosed with ADHD and 4.3% of children are taking medication for this disorder. Most types of medications used to treat ADHD can be addictive and may have major side effects. Stimulant medications such as Ritalin, Dexedrine and Adderall are the most common treatments for ADHD and side effects often include depression, anxiety and irritability. The CDC estimated nearly 3,100 people are admitted to emergency rooms each year due to stimulant drugs. An estimated 3.3 million Americans under the age of 19 and 1.5 million Americans over the age of 20 take ADHD medications. Pycnogenol was chosen for the study because it continues to scientifically demonstrate health benefits without serious side effects or addictive properties. Published findings have demonstrated Pycnogenol's beneficial effects in heart, circulatory, skin and cognitive function, among others. "ADHD is affecting the quality of life for so many children and their families. It is imperative that science explores natural means to provide expanded treatment options. We look forward to advancing this promising research," said Rohdewald. Pycnogenol is a natural plant extract originating from the bark of the Maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and organic acids, which offer extensive natural health benefits. The extract has been widely studied for the past 35 years and has more than 220 published studies and review articles ensuring safety and efficacy as an ingredient. Today, Pycnogenol is available in more than 400 dietary supplements, multi-vitamins and health products worldwide. For more information or a copy of this study, visit www.pycnogenol.com. ### Natural Health Science Inc., (NHS) based in Hoboken, New Jersey, is the North American distributor for Pycnogenol® (pic-noj-en-all) brand French Maritime Pine Bark Extract on behalf of Horphag Research. Pycnogenol® is a registered trademark of Horphag Research Ltd., Guernsey, and its applications are protected by U.S. patents #5,720,956 / #6,372,266 and other international patents. NHS has the exclusive rights to market and sell Pycnogenol® and benefits from more than 35 years of scientific research assuring the safety and efficacy of Pycnogenol® as a dietary supplement. For more information about Pycnogenol® visit our web site at www.pycnogenol.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software